Anchang Liu
- Molecular Biology
- Molecular Medicine top 2%
- Biomaterials top 10%
- Pharmaceutical Science top 2%
- Biomedical Engineering
- Topics
- Nanoparticle-Based Drug Delivery (7 papers)Curcumin's Biomedical Applications (6 papers)Nanoplatforms for cancer theranostics (5 papers)
In The Last Decade
Anchang Liu
48 papers receiving 854 citations
Peers
Comparison fields: 5 of 114
- Molecular Biology 346
- Molecular Medicine 276
- Biomaterials 160
- Pharmaceutical Science 135
- Biomedical Engineering 84
Countries citing papers authored by Anchang Liu
This map shows the geographic impact of Anchang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anchang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anchang Liu more than expected).
Fields of papers citing papers by Anchang Liu
This network shows the impact of papers produced by Anchang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anchang Liu. The network helps show where Anchang Liu may publish in the future.
Co-authorship network of co-authors of Anchang Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Anchang Liu. A scholar is included among the top collaborators of Anchang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anchang Liu. Anchang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 9 | |
| 5 | 0 | |
| 6 | 2 | |
| 7 | 14 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 5 | |
| 11 | 25 | |
| 12 | 9 | |
| 13 | 16 | |
| 14 | 64 | |
| 15 | 12 | |
| 16 | 5 | |
| 17 | 3 | |
| 18 | Study of Synthetic Process of Novel Neonicotinoid Dinotefuran | 1 |
| 19 | 27 | |
| 20 | 215 |
About Anchang Liu
Anchang Liu is a scholar working on Molecular Medicine, Pharmaceutical Science and Biomaterials, having authored 49 papers that have together received 877 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), Curcumin's Biomedical Applications (6 papers) and Nanoplatforms for cancer theranostics (5 papers). The work is most often cited by research in Molecular Medicine (276 citations), Pharmaceutical Science (135 citations) and Biomaterials (160 citations). Anchang Liu has collaborated with scholars based in China, Belarus and Finland. Frequent co-authors include Li-Xia Zhao, Hong‐Xiang Lou, Guangxi Zhai, Peihong Fan, Yanxiao Xiang, Yuan Gao, Jianbo Ji, Hua Zhao, Xiaoye Yang and Yuguo Chen. Their work appears in journals such as Analytical Chemistry, Chemical Engineering Journal and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.